对抗体阴性自身免疫脑炎的临床特征和与长期结果相关的因素的研究
Binhong Han1, Yuwei Dai1, Jian Peng1
1Department of Neurology, Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Annals of clinical and translational neurology
|April 22, 2024
概括
抗体阴性自身免疫脑炎 (AE) 呈现出多种结果,ANPRA亚型表现更差. 早期启动免疫治疗是改善AE患者长期预后的关键.
科学领域:
- 神经学 神经学
- 免疫学 免疫学 免疫学
- 临床医学 临床医学
背景情况:
- 在没有特定抗体标志物的情况下,自免疫脑炎 (AE) 诊断可能具有挑战性.
- 了解抗体阴性AE的临床谱和预后因素对于患者管理至关重要.
研究的目的:
- 为了表征抗体阴性AE患者.
- 确定抗体阴性AE的长期结果的预测因素.
- 为了验证预测结果的RAPID得分.
主要方法:
- 100名抗体阴性AE患者的回顾性分析 (2016年1月至2022年12月).
- 使用修改的兰金尺度 (mRS) 和自身免疫脑炎临床评估尺度 (CASE) 评估长期结果.
- 对结果的预测因素的分析和RAPID分数的外部验证.
主要成果:
- 49%的患者有不利的长期结果 (mRS ≥3).
- ANPRA亚型显示出比LE和ADEM更差的结果.
- 较高的峰值CASE得分和延迟免疫疗法 (≥30天) 与更糟糕的结果相关.
结论:
- ANPRA亚型与抗体阴性AE的较差长期结果有关.
- 早期启动免疫疗法显著改善了长期结果.
- 快速评分可以协助对抗体阴性AE的临床决策.
相关概念视频
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Immunological Memory
602
Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature...
602
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K


